ADENOCARCINOMA OF THE PANCREAS
Clinical trials for ADENOCARCINOMA OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF THE PANCREAS trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radioactive drug targets FAP-Positive tumors in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, LY4337713, in people with advanced cancers that have high levels of a protein called FAP. The cancers include certain types of ovarian, breast, pancreatic, colorectal, esophageal, stomach, and bile duct cancers. The study aims …
Matched conditions: ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a malaria drug boost chemo for pancreatic cancer?
Disease control Recruiting nowThis study tests whether adding hydroxychloroquine (a malaria drug) to standard chemotherapy before surgery can improve outcomes for people with resectable pancreatic cancer. About 40 participants will receive the drug combo, then undergo surgery to remove their tumor. The goal i…
Matched conditions: ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE1, PHASE2 • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Can surgery beat pancreatic cancer spread? new trial aims to find out
Disease control Recruiting nowThis trial tests whether removing both the main pancreatic tumor and small spots in the liver or lungs after chemotherapy can help patients. It includes 40 people whose cancer has spread to only a few spots. Everyone gets the same treatment: chemo first, then surgery if the cance…
Matched conditions: ADENOCARCINOMA OF THE PANCREAS
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could two old drugs boost chemo for pancreatic cancer?
Disease control Recruiting nowThis phase 2 trial tests whether adding valproic acid and simvastatin to standard chemotherapy can help people with untreated metastatic pancreatic cancer live longer without their disease getting worse. About 240 participants will be randomly assigned to receive either the stand…
Matched conditions: ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Sound waves vs. pancreatic cancer: new device tested in humans
Disease control Recruiting nowThis study tests a device called the HistoSonics Edison System, which uses focused sound waves (histotripsy) to mechanically break apart pancreatic tumors without surgery. The trial will enroll 50 adults with advanced pancreatic cancer that cannot be removed surgically. The main …
Matched conditions: ADENOCARCINOMA OF THE PANCREAS
Phase: NA • Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Pancreatic cancer surgery upgrade: remove the whole pancreas, then transplant its own cells to avoid diabetes
Disease control Recruiting nowThis study tests a two-step surgery for people with pancreatic or related cancers. Instead of the standard partial removal, doctors remove the entire pancreas and then transplant the patient's own insulin-making cells into the liver. The goal is to prevent a common complication (…
Matched conditions: ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC